时间标签：数据日期 2026-10-31 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/28–2026/10/31 ｜ 情报发生日期 2026-10-31
研究问题
Although targeting the complement system represents an attractive drug development strategy, it remains unclear which specific pathway and complement protein should be targeted for the optimal therapeutic outcome [].
方法
Other reagents include: DMEM/F12 (1:1; Gibco, cat#11320033), fetal bovine serum (Gibco, cat#10099158), penicillin/streptomycin (Gibco, cat#15140122), NHS (Gemini, cat#100‐512), SMM 293‐TII medium (Sinobiological, cat#M293TII), polyethylenimine (PEI) (Biohub International Trade, cat#78PEI4000), Ni‐NTA agarose (Smart Life Sciences, cat#SA004025), Avacincaptad pegol (synthesized by MCE), A2E (MCE, cat#HY‐134928A), C5b6 (CompTech, cat#122), C8 (CompTech, cat#125), C3a (MCE, cat#HY‐P7862), C5a (MCE, cat#HY‐P7864), C3aR antagonist (MCE, cat#HY‐101502A), C5aR antagonist (MCE, cat#HY‐17627), CD59‐Fc fusion protein (MCE, cat#HY‐P700683), TrypLE Express (Gibco, cat#12604013), anti‐C5b9 (Abcam, cat#ab66768, clone aE11), anti‐C3/C3b/iC3b/C3d (Biolegend, cat#846302, clone 1H8), goat anti‐mouse 647 secondary antibody (Abcam, cat#ab150115), goat anti‐rabbit 488 secondary antibody (Abcam, cat#ab150077),
核心结论
In contrast, 40% heat‐inactivated NHS (HI‐NHS) had no significant hemolytic effect and was used as a negative control (Figure ).；Consistent with previous research [], we demonstrated that A2E loading (Figure ) led to a downregulation of key complement regulatory proteins CD46, CD55, and CD59 (Figure ) on the cell surface, which is also observed in GA patients [].；This loss of intrinsic protection led to excessive complement activation upon NHS treatment, characterized by significant deposition of C5b9 and C3b on the RPE cell surface (Figure , and Figure ), and increased levels of C3a and C5a in culture supernatant (Figure ). ‖ 结论：These findings support further evaluation of sustained and effective C3 inhibition as a therapeutic strategy for GA secondary to AMD.
局限
We propose that this clinical‐mechanistic discordance can be explained by the limitations of current clinical endpoints and the significant challenges to inhibiting C3.；The conclusions drawn here therefore warrant further validation in more complex preclinical models in the future.
对本项目的价值
★☆☆☆☆ 皮肤是唯一可直接局部给药、可活检、可影像量化的器官，最快可验证 senotherapeutic 概念。
全文来源
PMC JATS 全文（正文 54,428 字符，已过标题/DOI 逐字归属校验）
原文题录
- 英文标题：A Mechanistic Dissection of Multifaceted Complement Attack in Age-Related Macular Degeneration Reveals the Superiority of C3 Inhibition.
- 期刊与标识：Adv Sci (Weinh) · PMID 42949647 · DOI 10.1002/advs.78539
A 级证据分级：A 级（同行评议人体研究）
本文属人体研究证据，但需注意：观察性或小样本干预的结论不等于已证实临床获益；效应量与长期安全性仍需更大规模、更长随访的试验验证。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。